CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Pharming Group NV - CapyFin

Pharming Group NV

PHAR · Euronext Amsterdam🇳🇱

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Previous year: €81.2M

Previous year: -€0.04

Operating Margin

Gross Profit Margin

Net Profit Margin

Cash and Equivalents

Loading...

Key Statistics

Market Cap

$1.42B

P/E Ratio

-6.07

Sector

N/A

Industry

N/A

52-Week High

$1.77

52-Week Low

$0.688

Operating Margin

7.2%

Gross Profit Margin

86.8%

Net Profit Margin

4%

Pharming Group NV

Unlock previous datapoints

Pharming Group NV

Unlock previous datapoints

Pharming Group NV Revenue by Segment

Pharming Group NV Revenue by Geographic Location

Revenue by Segment

RUCONEST® (US) Revenue

CapyFin.com

RUCONEST® (EU & RoW) Revenue

CapyFin.com

Joenja® (US) Revenue

CapyFin.com

Joenja® (EU & RoW) Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

EU & Rest of World Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...